Trademark: 79373992
Word
RONOMA
Status Date
Tuesday, September 10, 2024
Filing Date
Friday, May 26, 2023
Published for Opposition
Tuesday, October 15, 2024
5 Pharmaceutical products for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceuticals sold on prescription, namely those treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; chemical preparations for pharmaceutical or medical use, namely for diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical preparations against neurodegenerative diseases and diseases of the central nervous system; pharmaceutical preparations for combating the symptoms of Alzheimer's disease; Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations for all means of administration, namely pharmaceutical preparations for the treatment of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical solutions, gels and powders for all types of administration for the treatment of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical preparations for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's by intranasal administration; pharmaceutical solutions, gels and powders for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's by intranasal administration
35 Public relations; database management; establishing statistics in the nature of compilation of statistics for business or commercial purposes; sales promotions; organization of exhibitions for commercial and advertising purposes; organizing, managing, conducting exhibitions, fairs for advertising or commercial purposes; collection and systematization of data for business purposes in a central file in the field of pharmaceutical, health and medical research and development; retail store services or wholesale store services featuring pharmaceuticals products, pharmaceutical preparations against neurodegenerative diseases and diseases of the central nervous system, pharmaceutical preparations for combating symptoms of Alzheimer's disease, pharmaceutical preparations for treating Alzheimer's disease, pharmaceutical solutions, gels and powders for all types of administration
44 Medical services; medical services relating to diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; treating symptoms relating to central nervous system diseases and neurodegenerative diseases, namely, health care services for treating symptoms relating to central nervous diseases and neurodegenerative diseases; treating diseases of the central nervous system and neurodegenerative diseases, namely, health care services for treating diseases of the central nervous system and neurodegenerative diseases; treating Alzheimer's disease and its symptoms, namely, health care services for treating Alzheimer's disease and its symptoms; medical information services; providing medical information; providing information in the field of diagnosing and treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's, via a website
42 Medical research; biological research; scientific research for medical purposes in the field of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; information with respect to medical and scientific research relating to diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; providing laboratory research services in the field of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; scientific research and development for medical purposes; scientific research in the field of chemistry; scientific research in the field of pharmacology; research and development of medicines; scientific research in the field of galenics; preclinical studies and research; clinical studies and research; consultancy with respect to pharmacology
Jul 18, 2023
Application Filing Receipt Mailed
Jul 13, 2023
Sn Assigned For Sect 66a Appl From Ib
Jul 14, 2023
New Application Office Supplied Data Entered
Feb 20, 2024
Assigned To Examiner
Feb 22, 2024
Non-Final Action Written
Mar 15, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Apr 8, 2024
Refusal Processed By Ib
Sep 5, 2024
Correspondence Received In Law Office
Sep 5, 2024
Teas/Email Correspondence Entered
Sep 5, 2024
Teas Response To Office Action Received
Sep 7, 2024
Approved For Pub - Principal Register
Feb 23, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Mar 14, 2024
Refusal Processed By Mpu
Trademark Alertz updated from USPTO on 2030-01-24
